




|
Announcements
ABBOTT VASCULAR INTERNATIONAL SELECTS CLINIVATION WORLDVIEW ®.
One of the world's leading vascular care manufacturers selects clinivation WorldView® as their enterprise solution for on-demand global regulatory intelligence.
Natick, MA, September 22, 2008
- clinivation, Inc. announced today that Abbott Vascular, a division of Abbott, has selected the clinivation WorldView® enterprise solution for On-Demand Global Regulatory Intelligence.
"Abbott Vascular is clearly an innovative global leader in vascular care, and we are pleased that they have chosen clinivation WorldView® for comprehensive, authoritative, and up-to-date global regulatory intelligence," said Richard Morroney, R.A.C., C.Q.A., clinivation's Vice President of Quality and Regulatory Solutions.
About clinivation WorldView® On-Demand Global Regulatory Intelligence
Clinivation WorldView® is the medical device and diagnostic industry's most comprehensive, authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory Intelligence. Providing clear, step-by-step market clearance regulations, processes, and guidance for >99% of the world markets, only clinivation WorldView® delivers tried-and-true intelligence from certified, practicing professionals with real-world experience.
About Abbott Vascular International
Headquartered in Northern California, Abbott Vascular, a division of Abbott, is one of the world's leading vascular care businesses. Abbott Vascular is uniquely focused on transforming the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education.
Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular, and coronary products, which are recognized internationally for their safety, effectiveness, and ease of use in treating patients with vascular disease.
For more information, please visit www.abbottvascular.com.
About Abbott
Abbott is a global, broad-based health care company with sales, manufacturing, research and development, and distribution facilities around the world. Abbott is devoted to discovering new medicines, new technologies, and new ways to manage health, and its products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott's areas of expertise include anesthesia, animal health, anti-infectives, cardiovascular care, diabetes care, hematology, immunodiagnostics and clinical chemistry, immunology, metabolics, neuroscience, nutrition, oncology, pain care, point of care, renal care, vascular care, and virology.
Throughout its 120+ year history, Abbott has been driven by the goal of advancing medical science to help people live healthier lives.
For more information, please visit www.abbott.com.
About clinivation, Inc.
Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.
Used in over 100,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.
The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.
Our core brands include the clinivation Global® xi market clearance platform, clinivation WorldView® on-demand regulatory intelligence, and clinivation Clinical Suite® and clinivation Registry Suite® electronic data capture and clinical data management software.
Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.
Visit clinivation online at www.clinivation.com
For further information:
For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.
|